Login
Related Links
Gene Therapy Research Institutes - Europe
- Finland - A.I. Virtanen Institute of Molecular Medicine, University of Kuopio
- Finland - Cancer Gene Therapy Group, University of Helsinki
- Israel - The Goldyne Savad Institiute of Gene Therapy, Hadassah, Jerusalem
- Italy - San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan
- Italy - TIGEM - Telethon Institute of Genetics and Medicine, Napoli
- Netherlands - Oncogenomics VUmc, Amsterdam
- Netherlands - Pharmaceutical Gene Modulation, Groningen
- Spain - Viral Vector Production Unit (UPV), Universitat Autonoma de Barcelona
- Sweden - Molecular Medicine and Gene Therapy, Lund University
- Turkey - Human Gene and Cell Therapy Center, Akdeniz University Hospitals and Clinics
The research is on cardiovascular, neurodegenerative, and metabolism-related diseases. Main target genes are vascular growth factors, and LDL receptor in cardiovascular area and cytotoxic genes in cancer therapy.
The group of Akseli Hemminki uses gene therapy and oncolytic viruses to improve the treatment of cancers lacking currently available effective modalities.
Research covers a wide range of diseases along three main tracks: cellular gene therapy, viral vectors and non-viral vectors. The Institute is headed by Prof. Eithan Galun, M.D.
The group headed by Luigi Naldini performs basic research on gene transfer technologies and new gene therapy strategies for immunodeficiencies, lysosomal storage disorders, thalassemia, hemofilia B.
The interest of group of Alberto Auricchio is to use Adeno-Associated Virus (AAV)-mediated gene transfer as potential therapy for ocular and metabolic diseases
The Gene Therapy research group aims to design new anti-cancer therapies using oncolytic adenoviruses and modulation of gene expression, with particular attention to the p53 tumor suppressor pathway.
The department is headed by Prof. Hidde Haisma and is focused on the development of drugs for the therapeutic manipulation of gene activity. The research is focused on cancer and inflammatory diseases.
UPV is a vector core specialized in the cloning, production and purification of adenovirus (human and canine) and adeno-associated virus (AAV) serotypes for public institutions and private companies all over the world.
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders: Diamond-Blackfan Anemia and Gaucher Disease.
The laboratory is headed by Prof. Dr. Salih Sanlioglu and his team are involved in the development of novel gene therapy methods for patients with type 2 diabetes using lentiviral vectors.
Info Research Centers
Overview of research institutes, centers and universities involved in pre-clinical and clinical gene therapy research:
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
 |
US & Canada |
|
Europe |
|
Australia |
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
Gene Therapy News
- Breakthrough gene therapy offers hope for Parkinson's disease patients - Study Finds
Sat, 02 Dec 2023 15:31:5 GMT - FDA OKs uniQure trial of AMT-191 gene therapy for Fabry disease - Fabry Disease News
Fri, 01 Dec 2023 20:52:5 GMT - Gene therapy market size to grow by USD 4,613.9 million from 2022 ... - PR Newswire
Fri, 01 Dec 2023 08:35:0 GMT - The future of cell and gene therapy manufacturing - - Pharmaceutical Technology
Fri, 01 Dec 2023 08:03:0 GMT - Biosimilar gene therapy the best approach for treatment of orphan diseases, says expert - The Hindu
Fri, 01 Dec 2023 03:39:0 GMT - Scientists find gene therapy reduces liver cancer in animal model - UC Davis Health
Thu, 30 Nov 2023 21:08:5 GMT - Rett syndrome gene therapy trial expanded to include patients aged ... - Healio
Thu, 30 Nov 2023 18:24:5 GMT - Generation Bio cuts 40% of staff in blow for non-viral gene therapy ... - Pharmaceutical Technology
Thu, 30 Nov 2023 16:46:3 GMT - Regenxbio Advances Phase I/II Trial for DMD Gene Therapy - Precision Medicine Online
Thu, 30 Nov 2023 15:48:0 GMT - German researchers welcome national, EU support for gene therapy ... - EURACTIV
Thu, 30 Nov 2023 09:01:1 GMT - Gene Therapy in Hemophilia A: Safety, Efficacy, and the Changing ... - Pharmacy Times
Thu, 30 Nov 2023 01:41:1 GMT - Accelerating Gene Therapy Production - Genetic Engineering & Biotechnology News
Wed, 29 Nov 2023 18:00:4 GMT - Team Develops Gene Therapy To 'Pre-Treat' Neuroblastoma Tumors - news.utdallas.edu
Wed, 29 Nov 2023 15:56:4 GMT - Gene Therapy: Greedflation moves thousands from your pocket to ... - Pittsburgh Post-Gazette
Wed, 29 Nov 2023 00:14:2 GMT - Demystifying Vector-Based Intravesical Gene Therapy for NMIBC: A ... - Urology Times
Tue, 28 Nov 2023 22:04:4 GMT